Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan<sup>®</sup>) in children.
- Published in:
- Eye (0950-222X), 2004, v. 18, n. 1, p. 24, doi. 10.1038/sj.eye.6700520
- By:
- Publication type:
- Article
Works matching DE "OPHTHALMIC drugs industry"
Results: 7
1
2
INDUSTRY NEWS IN BRIEF.
- Published in:
- Ocular Surgery News, 2010, v. 28, n. 6, p. 41
- By:
- Publication type:
- Article
3
Industry Pipeline.
- Published in:
- Ocular Surgery News, 2010, v. 28, n. 2, p. 38
- Publication type:
- Article
4
Ophthalmic Start-Up Chief Executive Officers' Perceptions of Development Hurdles.
- Published in:
- Ophthalmic Research, 2018, v. 59, n. 2, p. 110, doi. 10.1159/000479376
- By:
- Publication type:
- Article
5
Challenges facing ophthalmic start-up companies in developing new devices or medicines.
- Published in:
- Acta Ophthalmologica (1755375X), 2013, v. 91, n. 1, p. e81, doi. 10.1111/j.1755-3768.2012.02443.x
- By:
- Publication type:
- Article
6
Industry Pipeline.
- Published in:
- Ocular Surgery News, 2010, v. 28, n. 14, p. 20
- Publication type:
- Article
7
INDUSTRY NEWS IN BRIEF.
- Published in:
- Ocular Surgery News, 2010, v. 28, n. 14, p. 20
- Publication type:
- Article